Drugs and Devices

FDA approves Farydak for treatment of multiple myeloma

On February 23, the U.S. Food and Drug Administration (FDA) approved Farydak (panobinostat) for the treatment of patients with multiple myeloma. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares